Displaying 1 - 2 of 2

Patent agreement welcomed as step to improve HIV treatment

As we mark World AIDS Day 2015, the World Council of Churches-Ecumenical Advocacy Alliance (WCC-EAA) welcomes a license agreement between the Medicines Patent Pool (MPP) and Bristol Myers Squibb (BMS) for daclatasvir, an important direct acting antiviral that is proven to help cure multiple genotypes of the hepatitis C virus (HCV).